Comella, Pasquale and Lorusso, Vito and Maiorino, Luigi and Casaretti, Rossana and Cannone, Michele and Massidda, Bruno and Putzu, Carlo and Leo, Silvana and Roselli, Mario and Mancarella, Sergio and Palmeri, Sergio and Greco, Ettore and Vessia, Giacomo and Sandomenico, Claudia and Franco, Luca (2009) Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group. Cancer Chemotherapy and Pharmacology, Vol. 64 (5), p. 893-899. eISSN 1432-0843. Article.
Full text not available from this repository.
Methods. Patients with unresectable or metastatic gastric cancer, unexposed to palliative chemotherapy, received oxaliplatin 85 mg/m2 iv and irinotecan 150 mg/m2 iv on day 1, 6S-folinic acid 250 mg/m2 iv and fluorouracil 750 mg/m2 iv on day 2, every 2 weeks. Response rate (RR) was assessed after a minimum of four cycles, and treatment continued up to 12 cycles.
I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore
Repository Staff Only: item control page